Form 4: Cardio Diagnostics Director Acquires Stock Options

Cardio Diagnostics Holdings, Inc. Director James Intrater acquired stock options, indicating a potential future investment in the company.

Summary

• James Intrater, a Director at Cardio Diagnostics Holdings, Inc., acquired stock options on June 30, 2026.
• The options grant the right to buy 2,854 shares of common stock at an exercise price of $2.19 per share.
• These options are exercisable from June 30, 2026, to June 30, 2036.
• Following this transaction, Intrater beneficially owns 13,318 shares of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a standard insider transaction that signals confidence but does not involve immediate capital infusion or significant strategic shifts.

Positives

• Director James Intrater's acquisition of stock options suggests confidence in the company's future prospects.
• The acquisition of options at a specific price point ($2.19) may indicate a belief that the stock price will exceed this value.

Future Outlook

The acquisition of stock options by a director suggests a positive outlook on the company's future performance, as the options have value only if the stock price increases above the exercise price.

Industry Context

StockSavvy.ai notes that the acquisition of stock options by a director is a common practice in the healthcare technology sector, often used as an incentive and a way to align management's interests with those of shareholders.

Stakeholder Impact

• Shareholders: The acquisition of options by a director may be viewed positively, suggesting insider confidence in future stock performance. However, it does not immediately impact share count or value.
• Employees: This transaction is primarily related to director compensation and governance, with no direct immediate impact on general employees.
• Management: Aligns the director's financial interests with the company's stock performance.

Next Steps

• James Intrater may exercise his stock options between June 30, 2026, and June 30, 2036, if the stock price is favorable.

Key Dates

Keywords

Cardio Diagnostics Holdings, CDIO, Form 4, Stock Options, Director, Beneficial Ownership, SEC Filing